HER-2阳性转移性乳腺癌的临床试验
总计2535个结果
-
The First Affiliated Hospital with Nanjing Medical...Jiangsu HengRui Medicine Co., Ltd.招聘中
-
NRG OncologyNational Cancer Institute (NCI); Alliance for Clinical Trials in Oncology; Eastern Cooperative... 和其他合作者招聘中
-
First Affiliated Hospital Xi'an Jiaotong University招聘中
-
King's College LondonGuy's and St Thomas' NHS Foundation Trust; Brighton and Sussex University Hospitals NHS Trust招聘中
-
University of Texas Southwestern Medical CenterMerck Sharp & Dohme LLC; Breast Cancer Research Foundation主动,不招人
-
Fox Chase Cancer CenterGenentech, Inc.主动,不招人
-
Zhejiang Hisun Pharmaceutical Co. Ltd.完全的
-
Fondazione Policlinico Universitario Agostino Gemelli...主动,不招人
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University未知HER2阳性乳腺癌
-
Shandong University未知
-
National Cancer Institute (NCI)完全的
-
Dana-Farber Cancer InstituteNovartis终止
-
Saint Luke's Health SystemNovartis Pharmaceuticals招聘中
-
National Cancer Institute (NCI)完全的复发性乳腺癌 | 雌激素受体阴性 | 雌激素受体阳性 | HER2/Neu 阴性 | HER2/Neu阳性 | 孕激素受体阴性 | 孕激素受体阳性 | IIIC 期乳腺癌 AJCC v6 | IV 期乳腺癌 AJCC v6 和 v7美国, 波多黎各
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.招聘中
-
Latin American Cooperative Oncology GroupRoche Pharma AG; Oncoclínicas尚未招聘
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University招聘中
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.招聘中
-
Cancer Trials Ireland招聘中
-
Shengjing HospitalJiangsu HengRui Medicine Co., Ltd.招聘中
-
German Breast GroupRoche Pharma AG招聘中
-
iOMEDICO AGSeagen Inc.招聘中
-
Breast Cancer Trials, Australia and New Zealand招聘中
-
Cancer Institute and Hospital, Chinese Academy...招聘中
-
Shanghai Henlius Biotech主动,不招人
-
Daiichi Sankyo完全的